Search is Powered by Google
Cancer / Oncology News

One In Eight Advanced Cancer Patients Delays, Avoids Needed Treatment Because Of Cost Concerns, Analysis Finds

Main Category: Cancer / Oncology
Also Included In: Health Insurance / Medical Insurance
Article Date: 15 Oct 2008 - 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

One in eight advanced cancer patients delayed or avoided recommended treatment because of cost concerns, according to an analysis recently conducted by Thomson Reuters, USA Today reports. The unscientific analysis involved 1,767 patients who responded to an online questionnaire.

The analysis found that 25% of patients with annual incomes of less than $40,000 delayed or avoided recommended treatment. In addition, the analysis found that 12% of advanced colon cancer patients spent more than $25,000 out of pocket for treatment.

According to Joseph Singer of HealthCore, a health care research company, many of the medical advances that allow cancer patients to live longer have a high cost.

Many health insurers also have begun to require cancer patients to cover a larger share of the cost of their treatment -- as much as 20% in some cases -- Neal Meropol of the Fox Chase Cancer Center said.

As a result, groups that help cancer patients with the cost of their treatment have experienced increased demand. Diane Blum -- executive director of CancerCare, which provides cancer patients with social work and small grants for transportation expenses -- said that requests for help have increased by 30% in the past year (Szabo, USA Today, 10/13).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2008 Advisory Board Company and Kaiser Family Foundation.  All rights reserved.




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...